Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Palforzia oral immunotherapy for peanut allergy

Feb. 3, 2020

Gilead provides remdesivir for use in response to novel coronavirus

Feb. 3, 2020

Researchers develop an animal model of Marburg virus infection

Feb. 3, 2020

Eisai initiates phase II study of E-7090 in advanced cholangiocarcinoma with FGFR2 gene fusion

Feb. 3, 2020

Calibr begins first-in-human study of CCW-702 in metastatic castration-resistant prostate cancer

Feb. 3, 2020

DB-020 prevents cisplatin-induced hearing loss in animal model, enters clinical trial

Feb. 3, 2020

Eli Lilly and Company presents SERD inducers for cancer

Feb. 3, 2020

Rodin Therapeutics divulges HDAC inhibitors

Feb. 3, 2020

Gilead Sciences describes new IRAK-4 inhibitors

Feb. 3, 2020

GlaxoSmithKline discloses CREB2 inhibitors

Feb. 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...